These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 989807)

  • 1. Estrogen-containing oral contraceptive agents. A basis for their thrombogenicity.
    Wessler S; Gitel SN; Wan LS; Pasternack BS
    JAMA; 1976 Nov; 236(19):2179-82. PubMed ID: 989807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives and surgery: reduced antithrombin and antifactor Xa levels without postoperative venous thrombosis in low-risk patients.
    Gallus AS; Chooi CC; Konetschnik F; Goodall KT
    Thromb Res; 1984 Sep; 35(5):513-26. PubMed ID: 6484897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activated factor X-antithrombin III reaction rate: a measure of the increased thrombotic tendency induced by estrogen-containing oral contraceptives in rabbits.
    Gitel SN; Stephenson RC; Wessler S
    Haemostasis; 1978; 7(1):10-8. PubMed ID: 640489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen containing oral contraceptives and antithrombin III activity.
    Rákóczi I; Nagy I; Szigetvári I; Losonczy H; Hadnagy J; Gáti I
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):281-6. PubMed ID: 4471272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects on thrombosis and roral contraception].
    Astedt B
    Lakartidningen; 1975 Feb; 72(7):585-6. PubMed ID: 1113573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives: mechanisms in thromboembolism.
    Lancet; 1980 May; 1(8178):1118-9. PubMed ID: 6103446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and deep venous thrombosis with pulmonary embolism.
    Bouché RT; Medawar SJ; Dockery GL
    J Foot Surg; 1982; 21(4):297-301. PubMed ID: 7186920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and vascular thrombosis.
    Andrews WC
    South Med J; 1977 May; 70(5):519-20. PubMed ID: 323987
    [No Abstract]   [Full Text] [Related]  

  • 11. Small doses of heparin and a new concept of hypercoagulability.
    Wessler S
    Thromb Diath Haemorrh; 1975 Feb; 33(1):81-6. PubMed ID: 1118831
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition.
    Panicucci F; Sagripanti A; Conte B; Pinori E; Vispi M; Lecchini L
    Haemostasis; 1980; 9(5):297-302. PubMed ID: 7409613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombin 3 changes in women using oral contraceptives].
    Conard J; Salomon Y; Samama M
    Pathol Biol (Paris); 1974 Jan; 22(1):77-80. PubMed ID: 4592416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in relation to oral contraceptive use.
    Helmrich SP; Rosenberg L; Kaufman DW; Strom B; Shapiro S
    Obstet Gynecol; 1987 Jan; 69(1):91-5. PubMed ID: 3796927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep vein thrombosis and the oestrogen content in oral contraceptives. An epidemiological analysis.
    Kierkegaard A
    Contraception; 1985 Jan; 31(1):29-41. PubMed ID: 3987273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives.
    Von Kaulla E; Droegemueller W; Aoki N; Von Kaulla KN
    Am J Obstet Gynecol; 1971 Mar; 109(6):868-73. PubMed ID: 5552623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content.
    Böttiger LE; Boman G; Eklund G; Westerholm B
    Lancet; 1980 May; 1(8178):1097-101. PubMed ID: 6103437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis.
    Sagar S; Stamatakis JD; Thomas DP; Kakkar VV
    Lancet; 1976 Mar; 1(7958):509-11. PubMed ID: 55783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rabbit as an animal model for the activated factor X-antithrombin III-heparin reaction.
    Gitel SN; Wessler S; Medina VM
    Circ Res; 1977 Aug; 41(2):187-91. PubMed ID: 872292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.